Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner

MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global...

PACB : 1.7850 (-2.99%)
PacBio Earnings: What To Look For From PACB

PacBio Earnings: What To Look For From PACB

PACB : 1.7850 (-2.99%)
3 Cash-Burning Stocks We Approach with Caution

3 Cash-Burning Stocks We Approach with Caution

LOVE : 12.79 (-1.92%)
JELD : 2.49 (-10.43%)
PACB : 1.7850 (-2.99%)
PacBio Completes Sale of Short-Read Sequencing Assets

MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select...

PACB : 1.7850 (-2.99%)
3 Stocks Under $10 with Warning Signs

3 Stocks Under $10 with Warning Signs

PACB : 1.7850 (-2.99%)
BLNK : 0.6574 (-4.06%)
WU : 9.92 (+0.20%)
PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

MENLO PARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial...

PACB : 1.7850 (-2.99%)
3 Unpopular Stocks That Concern Us

3 Unpopular Stocks That Concern Us

PACB : 1.7850 (-2.99%)
HD : 390.53 (-0.04%)
M : 21.59 (-0.64%)
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration...

PACB : 1.7850 (-2.99%)
PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the...

PACB : 1.7850 (-2.99%)
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children’s...

PACB : 1.7850 (-2.99%)

Barchart Exclusives

Should You Bet on a Short Squeeze in Under Armour Stock?
Under Armour’s heavy short interest and sharp rebound have stirred volatility. Is another squeeze ahead, or is it over? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar